Bicocca Open Archive

Logo unimib boa

Cortes, J., Lipton, J., Kota, V., Castagnetti, F., Assouline, S., Brummendorf, T., et al. (2023). Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study. HAEMATOLOGICA, 108(12), 3454-3459 [10.3324/haematol.2022.281944].

Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study

Gambacorti-Passerini C.
2023
Lettera in rivista
Cross-intolerance, bosutinib, leukemia, tyrosine kinase inhibitors
English
1-dic-2023
2023
HAEMATOLOGICA
108
12
3454
3459
open
Cortes, J., Lipton, J., Kota, V., Castagnetti, F., Assouline, S., Brummendorf, T., et al. (2023). Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study. HAEMATOLOGICA, 108(12), 3454-3459 [10.3324/haematol.2022.281944].
01 - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
11145-Article Text-81536-2-10-20231129.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 206.53 kB
Formato Adobe PDF
Visualizza/Apri
206.53 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/472977
Citazioni
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
Social impact